UK markets closed

Adverum Biotechnologies, Inc. (ADVM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
10.43+0.43 (+4.30%)
At close: 04:00PM EDT
10.25 -0.18 (-1.73%)
After hours: 05:42PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
75,000
68,431
34,195
62,424
Other short-term investments
21,526
117,158
270,993
367,305
Total cash
96,526
185,589
305,188
429,729
Net receivables
-
0
5,709
0
Other current assets
6,247
5,006
6,248
4,709
Total current assets
102,773
190,595
317,145
434,438
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
81,542
130,855
132,234
57,173
Accumulated depreciation
-14,512
-16,994
-13,174
-10,072
Net property, plant and equipment
67,030
113,861
119,060
47,101
Other long-term assets
3,207
3,916
2,753
999
Total non-current assets
70,237
117,777
122,582
48,129
Total assets
173,010
308,372
439,727
482,567
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
1,921
2,238
1,387
2,810
Taxes payable
101
254
-
-
Accrued liabilities
3,718
7,386
5,503
3,919
Other current liabilities
725
417
2,017
1,285
Total current liabilities
24,914
32,246
21,320
20,871
Non-current liabilities
Other long-term liabilities
-
1,047
1,114
1,114
Total non-current liabilities
64,627
94,608
102,222
27,349
Total liabilities
89,541
126,854
123,542
48,220
Stockholders' equity
Common stock
10
10
10
10
Retained earnings
-919,777
-802,612
-648,076
-502,536
Accumulated other comprehensive income
-473
-1,531
-714
-261
Total stockholders' equity
83,469
181,518
316,185
434,347
Total liabilities and stockholders' equity
173,010
308,372
439,727
482,567